# US 2021/0330687 A1 · Bifidogenic hypoallergenic gos compositions and methods for providing the same involving beta-galactosidase from a strain of lactobacillus delbrueckii ssp bulgaricus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330687 A1
- Document ID: US20210330687A1
- Status: Published application
- Kind: A1
- Application number: 17/273,448
- Filed: 2019-09-04
- Published: 2021-10-28
- Earliest claimed: 2018-09-06
- Assignees: FrieslandCampina Nederland B.V.
- Applicants: FrieslandCampina Nederland B.V.
- Inventors: Linqiu Cao
- Web page: https://patentgrep.com/patent/US20210330687A1

## CPC

- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 31/702: Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12P 19/12: Disaccharides
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- C12Y 302/01023: Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The invention relates to the field of hypoallergenic oligosaccharides for use in nutritional compositions, in particular to oligosaccharides having prebiotic properties. Provided is a hypoallergenic oligosaccharide composition comprising galacto-oligosaccharides (GOS), wherein (i) the galacto-oligosaccharides (GOS) content is at least 40% by weight of the total dry matter of the composition; (ii) the allolactose content is at least 10% by weight of the total dry matter of the composition; (iii) the 6′-GL content is at least 30% by weight of the total GOS in the composition; and (iv) at least 0.5% by weight of the total GOS has a polymerization degree (DP) of six or more. The GOS composition does not trigger GOS-allergy as assessed in a basophil activation test (BAT).

## Claims

### Claim 1

An oligosaccharide composition comprising:
(i) at least 40% galacto-oligosaccharides (GOS) by weight of the total dry matter of the composition;
(ii) at least 10% allolactose by weight of the total dry matter of the composition;
(iii) at least 30% 6′-galactosyl-lactose (6′-GL) by weight of the total GOS in the composition; and
(iv) at least 0.5% by weight of the total GOS has a polymerization degree (DP) of six or more.

### Claim 2 (depends on 1)

The oligosaccharide composition of claim 1, wherein the GOS content is at least 42% by weight of the total dry matter of the composition.

### Claim 3 (depends on 1)

The oligosaccharide composition of claim 1, wherein at least 1% by weight of the total GOS has a DP of six or more.

### Claim 4 (depends on 1)

The oligosaccharide composition of claim 1, wherein the allolactose content is at least 12% by weight of the total dry matter of the composition.

### Claim 5 (depends on 1)

The oligosaccharide composition of claim 1, wherein the 6′-GL content is at least 40% by weight of the total GOS in the composition.

### Claim 6 (depends on 1)

The oligosaccharide composition of claim 1, wherein
(i) the GOS content is at least 70% by weight of the total dry matter of the composition;
(ii) the allolactose content is at least 12% by weight of the total dry matter of the composition;
(iii) the 6′-GL content is at least 40% by weight of the total GOS in the composition; and
(iv) at least 1% by weight of the total GOS has a polymerization degree (DP) of six or more.

### Claim 7 (depends on 1)

A nutritional composition comprising the oligosaccharide composition of claim 1, wherein said nutritional composition is an infant formula, a follow-up formula, a growing-up milk, a dairy product, a cereal, or a medical nutritional product.

### Claim 8 (depends on 1)

A nutritional composition comprising protein source, a lipid source, a carbohydrate source, and the oligosaccharide composition of claim 1.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

A method of promoting gut microbiota balance and health in a subject, the method comprising administering to the subject an effective amount of the oligosaccharide composition of claim 1.

### Claim 11 (depends on 10)

The method of claim 10, wherein said promoting gut microbiota and health comprises enhancing bifidogenic micro-organisms in the intestinal tract and/or improving patient tolerance to at least one medical treatment that leads to a gastrointestinal tract disorder.

### Claim 12 (depends on 1)

The oligosaccharide composition of claim 1, wherein the oligosaccharide composition has prebiotic properties effective to promote gut microbiota balance and health in an intestinal tract of a human or animal.

### Claim 13 (depends on 1)

A method of making a bifidogenic infant formula or dietetic food, the method comprising adding the oligosaccharide composition of claim 1 to a component selected from the group consisting of fats, carbohydrates, minerals, trace elements, vitamins, and combinations thereof.

### Claim 14 (depends on 1)

A method of making the oligosaccharide composition of claim 1, the method comprising (i) contacting a lactose feed with a beta-galactosidase (EC 3.2.1.23), and (ii) allowing for oligosaccharide synthesis, wherein said beta-galactosidase has an amino acid sequence having at least 98% sequence identity to SEQ ID NO:1.

### Claim 15 (depends on 14)

The method of claim 14, wherein said beta-galactosidase is contacted with said lactose feed while being present in a micro-organism endogenously expressing said beta-galactosidase, wherein said micro-organism is used as whole cells or an active part or fraction thereof, and the micro-organism is Lactobacillus delbrueckii subspecies bulgaricus strain DSM20080.

### Claim 16 (depends on 1)

The oligosaccharide composition of claim 1, wherein the GOS content is at least 60% by weight of the total dry matter of the composition.

### Claim 17 (depends on 1)

The oligosaccharide composition of claim 1, wherein at least 1.5% by weight of the total GOS has a DP of six or more.

### Claim 18 (depends on 1)

The oligosaccharide composition of claim 1, wherein the 6′-GL content is at least 43% by weight of the total GOS in the composition.

### Claim 19 (depends on 11)

The method of claim 11, wherein the at least one medical treatment is selected from the group consisting of radiotherapy, chemotherapy, gastrointestinal surgery, anesthesia, the administration of antibiotics, analgesic drugs, and treatment for diarrhea.

### Claim 20 (depends on 14)

The method of claim 14, wherein the beta-galactosidase (EC 3.2.1.23) is obtained from Lactobacillus delbrueckii subspecies bulgaricus strain DSM20080.
